Skip to main content
Journal cover image

The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up.

Publication ,  Journal Article
Treatment for Adolescents With Depression Study (TADS) Team, ; March, J; Silva, S; Curry, J; Wells, K; Fairbank, J; Burns, B; Domino, M; Feeny, N ...
Published in: Am J Psychiatry
October 2009

OBJECTIVE: The Treatment for Adolescents With Depression Study (TADS) evaluates the effectiveness of fluoxetine, cognitive-behavioral therapy (CBT), and their combination in adolescents with major depressive disorder. The authors report effectiveness outcomes across a 1-year naturalistic follow-up period. METHOD: The randomized, controlled trial was conducted in 13 academic and community sites in the United States. Stages I, II, and III consisted of 12, 6, and 18 weeks of acute, consolidation, and continuation treatment, respectively. Following discontinuation of TADS treatments at the end of stage III, stage IV consisted of 1 year of naturalistic follow-up. The participants were 327 subjects between the ages of 12 and 17 with a primary DSM-IV diagnosis of major depressive disorder. No TADS treatment was provided during the follow-up period; treatment was available in the community. The primary dependent measures, rated by an independent evaluator blind to treatment status, were the total score on the Children's Depression Rating Scale-Revised and the rate of response, defined as a rating of much or very much improved on the Clinical Global Impressions improvement measure. RESULTS: Sixty-six percent of the eligible subjects participated in at least one stage IV assessment. The benefits seen at the end of active treatment (week 36) persisted during follow-up on all measures of depression and suicidality. CONCLUSIONS: In contrast to earlier reports on short-term treatments, in which worsening after treatment is the rule, the longer treatment in the TADS was associated with persistent benefits over 1 year of naturalistic follow-up.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am J Psychiatry

DOI

EISSN

1535-7228

Publication Date

October 2009

Volume

166

Issue

10

Start / End Page

1141 / 1149

Location

United States

Related Subject Headings

  • United States
  • Treatment Outcome
  • Severity of Illness Index
  • Selective Serotonin Reuptake Inhibitors
  • Psychiatry
  • Male
  • Longitudinal Studies
  • Humans
  • Follow-Up Studies
  • Fluoxetine
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Treatment for Adolescents With Depression Study (TADS) Team, ., March, J., Silva, S., Curry, J., Wells, K., Fairbank, J., … Bartoi, M. (2009). The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up. Am J Psychiatry, 166(10), 1141–1149. https://doi.org/10.1176/appi.ajp.2009.08111620
Treatment for Adolescents With Depression Study (TADS) Team, Marla, John March, Susan Silva, John Curry, Karen Wells, John Fairbank, Barbara Burns, et al. “The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up.Am J Psychiatry 166, no. 10 (October 2009): 1141–49. https://doi.org/10.1176/appi.ajp.2009.08111620.
Treatment for Adolescents With Depression Study (TADS) Team, March J, Silva S, Curry J, Wells K, Fairbank J, et al. The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up. Am J Psychiatry. 2009 Oct;166(10):1141–9.
Treatment for Adolescents With Depression Study (TADS) Team, Marla, et al. “The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up.Am J Psychiatry, vol. 166, no. 10, Oct. 2009, pp. 1141–49. Pubmed, doi:10.1176/appi.ajp.2009.08111620.
Treatment for Adolescents With Depression Study (TADS) Team, March J, Silva S, Curry J, Wells K, Fairbank J, Burns B, Domino M, Vitiello B, Severe J, Riedal K, Goldman M, Feeny N, Findling R, Stull S, Baab S, Weller EB, Robbins M, Weller RA, Jessani N, Waslick B, Sweeney M, Dublin R, Walkup J, Ginsburg G, Kastelic E, Koo H, Kratochvil C, May D, LaGrone R, Vaughan B, Albano AM, Hirsch GS, Podniesinki E, Chu A, Reincecke M, Leventhal B, Rogers G, Jacobs R, Pathak S, Wells J, Lavanier SA, Danielyan A, Rohde P, Simons A, Grimm J, Frank S, Emslie G, Kennard B, Hughes C, Mayes TL, Rosenberg D, Benazon N, Butkus M, Bartoi M. The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up. Am J Psychiatry. 2009 Oct;166(10):1141–1149.
Journal cover image

Published In

Am J Psychiatry

DOI

EISSN

1535-7228

Publication Date

October 2009

Volume

166

Issue

10

Start / End Page

1141 / 1149

Location

United States

Related Subject Headings

  • United States
  • Treatment Outcome
  • Severity of Illness Index
  • Selective Serotonin Reuptake Inhibitors
  • Psychiatry
  • Male
  • Longitudinal Studies
  • Humans
  • Follow-Up Studies
  • Fluoxetine